Lesion Management Applications Developed for Chest and Abdominal CT Scans.

The LMS-Lung is intended to help the radiologists detect, quantify, and follow pulmonary nodules, and the LMS-Liver to facilitate the initial evaluation and the follow-up of liver lesions. Both applications also generate reports according to RECIST (Response Evaluation Criteria in Solid Tumors) criteria used to evaluate the response to treatment of solid tumors. LMS-Colon provides clinicians with advanced functionalities to help them detect and quantify polyps.

"All LMS applications are designed to be integrated in clinical routine and contribute to improve the workflow and productivity,” says Gerard Milhiet, COO of Median Technologies. "This improvement is achieved by automating all the tedious tasks the radiologists would normally carry out manually, and by integrating the applications with PACS or RIS workstations.”

This integration provides access to previous exams necessary to perform follow-up studies, brings additional clinical functionalities to the radiologists' desktop wherever needed in the hospital, and ensures an immediate report transmission to the referring physicians.

Fredrik Brag, CEO of Median Technologies commented, when asked about the company's future plans, "we have chosen the road of CT oncology which mainly consists in evaluating and following cancerous or other suspicious lesions. We already offer a comprehensive portfolio of applications in this field and aim at extending it.”

Median Technologies develops and commercializes advanced clinical applications for diagnostic oncology imaging.


Related Links:
Median Technologies